Latest Breaking News On - Aitor aguirre - Page 7 : comparemela.com

 E-Mail IMAGE: The clinical trial is the first step toward the team s overall goal: Developing a platform that combines radiotherapy with immunotherapy, drugs that help a patient s own immune system fight off. view more  Credit: Creative commons via Pxhere A potential new weapon against cancer is entering the first phase of clinical trials thanks to a collaboration between Spectrum Health, the Lansing-based company Niowave and Michigan State University. MSU s Kurt Zinn, a professor of biomedical engineering, radiology and small animal clinical sciences, is leading the effort to validate an innovative radiotherapy as part of a safe, more effective and potentially less costly treatment for bladder cancer.

Mark delanoTomasz timekMike zamiaraTerry grimmAitor aguirreKurt zinnNate kauffmanGlobal impact initiativeInstitute for quantitative health scienceMichigan state universityDrug administrationCollege of human medicine division radiologyDepartment of surgeryCancer researchSpectrum health cancer centerCardinal health